{
    "2021-12-06": [
        [
            {
                "time": "2021-12-03",
                "original_text": "医保谈判目录公布：国产创新药占比历年新高 首次关注高值罕见病创新药",
                "features": {
                    "keywords": [
                        "医保谈判",
                        "国产创新药",
                        "高值罕见病"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-05",
                "original_text": "医药行业周报：医保谈判结果出炉 持续鼓励创新",
                "features": {
                    "keywords": [
                        "医保谈判",
                        "创新"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-04",
                "original_text": "首席周观点：周期股会来第二春吗？",
                "features": {
                    "keywords": [
                        "周期股",
                        "第二春"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "周期股"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-06",
                "original_text": "医药行业周报：国谈结果出炉 政策趋于平缓",
                "features": {
                    "keywords": [
                        "国谈结果",
                        "政策平缓"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-07",
                "original_text": "医药行业一周观察：医保谈判落地 国产创新药收获颇丰",
                "features": {
                    "keywords": [
                        "医保谈判",
                        "国产创新药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-08",
                "original_text": "新股前瞻 | 贝达药业(300558.SZ)再赴港，肺癌药物研发的三代战略怎么打？",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "肺癌药物",
                        "三代战略"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-09",
                "original_text": "贝达药业非小细胞肺癌新药在美获批临床试验",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "非小细胞肺癌",
                        "临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-10",
                "original_text": "医药日报 | 腾盛博药新冠联合疗法III期临床数据积极",
                "features": {
                    "keywords": [
                        "腾盛博药",
                        "新冠联合疗法",
                        "III期临床"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-02",
                "original_text": "21健讯Daily｜医保基金飞检管理办法出台；研究发现奥密克戎有“弱病毒”基因",
                "features": {
                    "keywords": [
                        "医保基金",
                        "飞检管理办法",
                        "奥密克戎",
                        "弱病毒基因"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-06",
                "original_text": "A股早报2021年12月6日星期一",
                "features": {
                    "keywords": [],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}